Global hepatitis C situation



  • Globally, an estimated 71 million people are living with chronic hepatitis C (HCV), and almost 399,000 were estimated to have died from HCV-related liver disease in 2017.
  • The most affected regions are the Eastern Mediterranean and European Regions, with a prevalence of 2.3% and 1.5% respectively.
  • Prevalence of HCV infection in other regions varies from 0.5% to 1.0%.
Source: World Health Organisation (WHO), 2018

Hepatitis C in Australia


  • In 2016, an estimated 199,412 people were living with chronic HCV in Australia.
  • The major mode of transmission of HCV is through sharing or re-using injecting equipment which has been contaminated by infected blood.
  • A number of people from culturally and linguistically diverse backgrounds acquire HCV through unsterile medical procedures overseas. (NSW Hepatitis C Strategy 2014-2020)
  • An estimated 32,550 people received HCV treatment in 2016 with 93% of those cured.

Hepatitis C in culturally and linguistically diverse communities in Australia

  • 10-15% of people living with hepatitis C come from diverse backgrounds in 2016*.
  • A number of people from culturally and linguistically diverse backgrounds acquire HCV through unsterile medical procedures overseas.

Source: *Prof Greg Dore, Kirby Institute (2018 Personal communication)

Hepatitis C in NSW

  • An estimated 77,083 people were living with chronic HCV infection in NSW in 2016.
  • 558,559 tests for HCV were performed in NSW in 2017, a 5.5 per cent increase from 2016 (529,651 tests).
  • 14,102 (18.3%) people started HCV treatment in early 2017.
Source: HCV Mapping National Report 2016 and NSW Health